Supplemental material
Substance Abuse
Volume 43, 2022 - Issue 1
Commentary
Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies
Traci C. Greena Opioid Policy Research Collaborative, The Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, USA;b COBRE on Opioids and Overdose and the Department of Emergency Medicine, Rhode Island Hospital, Providence Rhode Island, USACorrespondence[email protected]
https://orcid.org/0000-0002-7924-7000View further author information
, PhD, MSchttps://orcid.org/0000-0002-7924-7000View further author information, Jeffrey Bratbergc University of Rhode Island College of Pharmacy, Kingston, Rhode Island, USAhttps://orcid.org/0000-0002-2240-5768View further author information
, PharmDhttps://orcid.org/0000-0002-2240-5768View further author information, Adriane N. Irwind Oregon State University College of Pharmacy, Corvallis, Oregon, USAhttps://orcid.org/0000-0002-9384-0134View further author information
, PharmD, MShttps://orcid.org/0000-0002-9384-0134View further author information, Jesse Boggisa Opioid Policy Research Collaborative, The Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, USAhttps://orcid.org/0000-0002-9413-7002View further author information
, MPHhttps://orcid.org/0000-0002-9413-7002View further author information, Mary Graye Comagine Health, Portland, Oregon, USAhttps://orcid.org/0000-0001-5841-4095View further author information
, PhDhttps://orcid.org/0000-0001-5841-4095View further author information, Gillian Leichtlinge Comagine Health, Portland, Oregon, USAhttps://orcid.org/0000-0003-3851-5758View further author information
, BAhttps://orcid.org/0000-0003-3851-5758View further author information, , BS, Anthony Floydf University of Washington, University of Washington, Seattle, Washington, USAhttps://orcid.org/0000-0002-1063-0132View further author information
, PhDhttps://orcid.org/0000-0002-1063-0132View further author information, Zain Al-Jammalid Oregon State University College of Pharmacy, Corvallis, Oregon, USAhttps://orcid.org/0000-0001-7127-3434View further author information
, PharmDhttps://orcid.org/0000-0001-7127-3434View further author information, , PharmD, Ryan Hansenf University of Washington, University of Washington, Seattle, Washington, USAhttps://orcid.org/0000-0001-5571-6434View further author information
, PhD, PharmDhttps://orcid.org/0000-0001-5571-6434View further author information & Daniel Hartungd Oregon State University College of Pharmacy, Corvallis, Oregon, USAhttps://orcid.org/0000-0002-0685-773XView further author information
, PharmD, MPHhttps://orcid.org/0000-0002-0685-773XView further author information show all